Industry News
Zytiga - New Prostate Cancer Drug
Jun 08, 2012
Results from a phase III trial reveal that men with advanced prostate cancer can significantly benefit from a new medication, abiraterone acetate, called Zytiga. The researchers found that the drug maintained patients' quality of life, slowed down the spread of cancer, and delayed the development of pain and deterioration of the patients' overall condition... Read More
Zytiga - New Prostate Cancer Drug
Jun 08, 2012
Results from a phase III trial reveal that men with advanced prostate cancer can significantly benefit from a new medication, abiraterone acetate, called Zytiga. The researchers found that the drug maintained patients' quality of life, slowed down the spread of cancer, and delayed the development of pain and deterioration of the patients' overall condition... Read More
New Drug Effective In Treating Skin Cancer
Jun 08, 2012
A new drug has been shown to be effective in treating and preventing the most common cancer in the United States: basal cell carcinoma skin cancer, according to a new study in the New England Journal of Medicine... Read More
Evolution Of Brain Tumor Cells Under Treatment Reveal That It Is The Peripheral Tumor Cells That Need To Be Targeted
Jun 08, 2012
An Israeli physicist has developed a theoretical model to simulate the evolution of highly proliferating brain tumour core cells subjected to treatment by alternating radio frequency electric field. The research, by Alexander Iomin from the Israel Institute of Technology Technion in Haifa, is about to be published in EPJ E¹... Read More
Fewer Side Effects From Nanomedicines For Cancer Treatment
Jun 08, 2012
A new generation of cancer treatments based on nanotechnology is making its way out of the laboratory and into the clinic with the promise of targeting cancer cells while steering clear of healthy tissue, according to the current edition of Chemical & Engineering News (C&EN;). C&EN; is the weekly newsmagazine of the American Chemical Society (ACS), the world's largest scientific society... Read More
Metastatic Breast Cancer May Be Slowed By HIV Drug
Jun 08, 2012
The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study published in a recent issue of Cancer Research... Read More
Metastatic Breast Cancer May Be Slowed By HIV Drug
Jun 08, 2012
The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study published in a recent issue of Cancer Research... Read More
CT Scans Raise Cancer Risk For Children
Jun 08, 2012
With MRI scans becoming cheaper and more common, perhaps the days of the CT scan that does a similar function using X-Rays rather than magnetic fields, are numbered. A report shows that the cancer risk from CT scans, especially Brain Cancer and Leukemia can triple in some cases... Read More
Tumors Start To Develop As A Result Of Specific Combinations Of Errors In The Processes That Safeguard Cell Integrity
Jun 08, 2012
A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors... Read More
Childhood Cancer Survivors Have High Risk Of Gastrointestinal Cancers Later On
Jun 07, 2012
Individuals who survive cancer before age 21 are nearly 5 times more likely to subsequently develop gastrointestinal (GI) cancers, researchers from the University of Chicago Medicine reported in the Annals of Internal Medicine... Read More
Previous Page Next Page